Harrow Inc Sustainability Reports
Harrow, Inc. is an eyecare pharmaceutical company that discovers, develops, and commercializes ophthalmic pharmaceutical products. The company offers compounded and branded formulations for managing ophthalmic diseases and surgical perioperative care.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900AP4LIRLNV8A089
FIGI: BBG001SSTRN9
7 reports from 2018 to 2025
